Portage Biotech
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors (NCT04969315) | Portage Biotech | 2023-06-23 |
Track Portage Biotech automatically
Every clearance here is in the API, with alerts when new ones post.